NEWS HOME

»

COVAXIN

 

Germany to recognize Bharat Biotech's COVAXIN for travel from June 1

German Ambassador to India, Walter J Lindner, on Thursday hailed the German government for recognizing the WHO-listed Bharat Biotech's COVID vaccine, COVAXIN, for travel to the country starting June 1.... read..

---

 

FDA removes hold on clinical trial for phase 2,3 for COVAXIN-BBV152 says Ocugen

Biotechnology company Ocugen on Monday announced that the US Food and Drug Administration (FDA) lifted the clinical hold on the Company's Phase 2, 3 clinical trials for COVAXIN™ (BBV152).... read..

---

 

Bharat Biotech seeks nod for Covaxin booster trials for 2-18 age group

Hyderabad-based vaccine manufacturer Bharat Biotech has sought permission to conduct booster dose trials of its Covid vaccine Covaxin for below 18 population.... read..

---

 

Bharat Biotech seeks DCGI's permission to conduct Covaxin booster trials in 2-18 age group

Hyderabad-based pharma company Bharat Biotech has sought permission from the Drugs Controller General of India (DCGI) to conduct trials of Covaxin as COVID-19 vaccine booster dose in the 2-18 age group, sources said.... read..

---

 

Restricted emergency use approvals to Covishield, Covaxin not granted in haste: SC

The Supreme Court on Monday said the material provided by the Centre does not warrant the conclusion that restricted emergency use approvals were granted to Covishield and Covaxin in haste, without thorough review of relevant data.... read..

---

 

DCGI approves COVID-19 vaccine Covaxin for children aged 6-12

The Drugs Controller General of India (DCGI) on Tuesday granted an emergency use authorisation (EUA) to Bharat Biotech's Covaxin for the age group of 6-12 years.... read..

---

 

DCGI gives emergency use authorisation to Covaxin for 6-12 age group

The Drugs Controller General of India (DCGI) gives restricted emergency use authorisation to Covaxin for the 6-12 age group.... read..

---

 

Bharat Biotech asked to provide more data on COVID-19 vaccine Covaxin for below 12-year-olds

The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has asked Bharat Biotech for additional data on its COVID-19 vaccine, Covaxin, for administering it to children aged between 2-12 years, sources said.... read..

---

 

Expert panel of DCGI holds meet to discuss recommendations to use COVID-19 vaccines Corbevax, Covaxin for 5-12 age group

The meeting of the Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is underway to discuss recommendations on restricted emergency use of Bharat Biotech's Covaxin and Biological E's Corbevax COVID-19 vaccine for children aged ... read..

---

 

Ocugen to commercialize Covaxin in Mexico, rights now encompassing all of North America

Biotechnology company Ocugen and Bharat Biotech (BBIL), on Monday, announced that they have entered into an amendment to their Co-development, Supply and Commercialization Agreement to expand Ocugen's exclusive territory to include commercialization of CO... read..

---

 

COVID vaccine: Covaxin price reduced from Rs 1,200 to Rs 225 per dose for private hospitals

Welcoming the decision to make precautionary dose available for all adults, Hyderabad-based vaccine manufacturer Bharat Biotech on Saturday, announced that it has revised the price of its COVID vaccine Covaxin from Rs 1,200 to Rs 225 per dose for private ... read..

---

 

Covaxin supply suspension by WHO not to impact travel by people: MEA

World Health Organization (WHO) suspending the supply of Covaxin through UN procurement agencies over "process and facility upgrade" requirements will not have an impact on travel by those who have taken the COVID vaccine, Ministry of External Affairs sai... read..

---

 

Japan recognizes India's COVAXIN to facilitate travel between both countries

Japan recognizes India's COVID-19 vaccine COVAXIN manufactured by Bharat Biotech with effect from April 10 to further facilitate travel from India to Japan, said the Indian Embassy in Japan on Thursday.... read..

---

 

Bharat Biotech upgrading facilities as WHO suspends Covaxin supplies

After the World Health Organisation (WHO) suspended the supply of Bharat Biotech's Covaxin vaccine under the United Nations (UN) procurement after an inspection last month, the company has said it is working on upgrades to ensure that the production of Co... read..

---

 

Bharat Biotech to rectify issues raised by WHO on Covaxin soon: Sources

Hyderabad-based pharmaceutical company, Bharat Biotech will rectify the issues raised by the World Health Organization regarding its COVID-19 vaccine-- Covaxin-- in a few days and added that the company has informed about this development to the Drugs Con... read..

---

 

WHO suspension for Covaxin supply only for UN agencies: Sources

The World Health Organization's (WHO) suspension of supplies of Covaxin of the Bharat Biotech supply is not related to safety or efficacy issues but only to supply for United Nations agencies, sources said.... read..

---

 

No impact on efficacy and safety of Covaxin: Bharat Biotech after WHO suspension

Hyderabad-based Bharat Biotech on Sunday issued a clarification that there is "no impact on efficacy and safety of the COVID-19 vaccine COVAXIN" after the World Health Organisation suspended it from its Covax facility.... read..

---

 

Bharat Biotech temporarily slows down COVAXIN production for facility optimization

Bharat Biotech on Friday announced the temporary slowing down of production of COVAXIN across its manufacturing facilities, having completed its supply obligations to procurement agencies and foreseeing the decrease in demand.... read..

---

 

Covaxin-maker Bharat Biotech MD D Krishna Ella, Joint MD Suchitra Ella conferred with Padma Bhushan

Bharat Biotech Managing Director (MD) D Krishna Ella and Joint MD Suchitra Ella received the Padma Bhushan award from President Ram Nath Kovind on Monday.... read..

---

 

Covaxin underwent all necessary trials, findings widely published, SC told

Bharat Biotech International Ltd has told the Supreme Court that Covaxin has undergone all necessary clinical trials and the Phase 3 efficacy trials revealed the vaccine is 77.8 per cent effective against Covid.... read..

---

 

COVID-19: FDA gives clearance to Covaxin for clinical trials in adults in US

Bharat Biotech's COVID-19 vaccine Covaxin has been given clearance for clinical trials in adults by the US Food and Drug Administration (FDA).... read..

---

 

Covaxin to be evaluated as COVID-19 vaccine candidate in US: Bharat Biotech

Hyderabad-based Bharat Biotech on Saturday said its COVID-19 vaccine Covaxin will be evaluated as a vaccine candidate for the disease in the United States.... read..

---

 

COVAXIN approved for emergency use in 13 countries: MoS for Health Bharati Pravin Pawar

Covaxin has been granted approval for emergency use in 13 countries as of January 31, 2022, according to the WHO, said Minister of State (MoS) for Health Bharati Pravin Pawar in Lok Sabha on February 4.... read..

---

 

DCGI grants conditional market approval for Covaxin, Covishield

The Drugs Controller General of India (DCGI) on Thursday granted conditional regular market approval for COVID-19 vaccines Covaxin and Covishield for restricted use in emergency situations in the adult population.... read..

---

 

Covaxin, Covishield given normal new drug permission in adult population with conditions: Health Minister

Union Health Minister Dr Mansukh Mandaviya on Thursday said that the Central Drugs Standard Control Organisation (CDSCO) has now upgraded the permission for Covaxin and Covishield from restricted use in emergency situations to normal new drug permission i... read..

---

 

DGCI grants conditional market approval for Covaxin, Covishield

The Drugs Controller General of India (DCGI) on Thursday granted conditional regular market approval for COVID-19 vaccines Covaxin and Covishield for restricted use in emergency situations in the adult population.... read..

---

 

Regular market approval to Covishield, Covaxin expected soon after final price fixation: Sources

The regular market approval from Drugs Controller General of India (DCGI) to COVID-19 vaccine Covishield and Covaxin is expected soon, but only after price fixation which is still underway, official sources told ANI on Wednesday.... read..

---

 

Covaxin maker Bharat Biotech Chairman Krishna Ella, wife Suchitra Ella to be awarded Padma Bhushan on Republic Day

Bharat Biotech Chairman Krishna Ella and co-founder Suchitra Ella will be conferred with Padma Bhushan on the 73rd Republic Day.... read..

---

 

Covishield, Covaxin cleared for regular market approval

India's two main vaccines -- Bharat Biotechs Covaxin and Serum Institute of India's Covishield -- on Wednesday got the nod for regular market authorisation.... read..

---

 

SEC recommends regular market approval to Covaxin, Covishield for adults

The Drugs Controller General of India's (DCGI) subject expert committee (SEC) has recommended the regular market approval to Serum Institute of India and Bharat Biotech for their COVID-19 vaccines Covaxin and Covishield with conditions for the adult popul... read..

---

 

Ensure only Covaxin is given to 15-18 group: Bharat Biotech

Bharat Biotech has urged healthcare workers to ensure that only Covaxin is administered to individuals in the 15-18 years age group.... read..

---

 

COVID-19: Bharat Biotech requests healthcare workers to ensure only COVAXIN is administered to 15-18 age group

Following reports of unapproved COVID vaccines being given to 15-18 year age group, Bharat Biotech on Tuesday requested healthcare workers to ensure that only COVAXIN is administered to individuals of the group.... read..

---

 

SEC asks for more data to grant full market approval to Covaxin and Covishield

The Drugs Controller General of India's (DCGI) Subject Expert Committee (SEC) will continue thorough review of data submitted by the Serum Institute of India (SII) and Bharat Biotech for granting full market approval to Covaxin and Covishield, sources tol... read..

---

 

DCGI's SEC to review applications of Bharat Biotech, SII for full market approval to Covaxin, Covishield today: Sources

Drugs Controller General of India (DCGI)'s Subject Expert Committee will review applications of Bharat Biotech and Serum Institute of India (SII) for full market approval to Covaxin and Covishield respectively on Friday, sources said.... read..

---

 

COVID-19 vaccine Covaxin now universal vaccine for adults, children: Bharat Biotech

Hyderabad-based vaccine manufacturer Bharat Biotech on Thursday announced that its indigenously developed COVID-19 vaccine Coavaxin is now a universal vaccine for adults and children.... read..

---

 

Covaxin can neutralise Delta, Omicron variants of coronavirus: Bharat Biotech

Hyderabad-based Bharat Biotech on Wednesday claimed that its COVID vaccine Covaxin can neutralise both Delta and Omicron variants of coronavirus.... read..

---

 

COVID-19: Third Covaxin dose holds promise, says ICMR as India prepares to administer 'precaution' doses from tomorrow

The third dose of Covaxin holds promise, the Indian Council of Medical Research said on Sunday just a day before the government plans to administer 'precaution' doses of COVID-19 vaccines to frontline workers, healthcare workers and senior citizens with c... read..

---

 

Covaxin booster dose trial shows 'long-term safety': Bharat Biotech

Hyderabad-based vaccine manufacturer Bharat Biotech said on Saturday that its trials for Covaxin booster dose have shown 'long-term safety with no serious adverse events'.... read..

---

 

COVID-19: Bharat Biotech urges healthcare workers to ensure administration of only Covaxin to 15-18 years agegroup

Hyderabad-based vaccine manufacturer Bharat Biotech on Friday said that it has received reports of COVID-19 vaccines other than Covaxin are being administered in children of age group 15-18 years in the country and urged healthcare workers to ensure admin... read..

---

 

Paracetamol not recommended after getting Covaxin jab: Bharat Biotech

Vaccine maker Bharat Biotech on Wednesday clarified that Paracetamol or pain killers are not recommended for teenagers after being vaccinated with Covaxin.... read..

---

 

No paracetamol or pain killers are recommended after being vaccinated with Covaxin: Bharat Biotech

Hyderabad-based vaccine manufacturer Bharat Biotech on Wednesday said that no paracetamol or pain killers are recommended after being vaccinated with COVID-19 vaccine Covaxin.... read..

---

 

COVID-19: India supplies 5 lakh more Covaxin doses to Afghanistan

Bharat Biotech on Monday informed that India has supplied another batch of humanitarian assistance consisting of 5,00,000 doses of COVID-19 vaccine, Covaxin to Afghanistan.... read..

---

 

33.2 lakh students in TN to be given Covaxin from Jan 3

Tamil Nadu health department will be inoculating 33.2 lakh students with Covaxin from January 3 onwards.... read..

---

 

India supplies 5 lakh Covaxin doses to Afghanistan

India supplied humanitarian assistance consisting of 5,00,000 Covaxin doses to Afghanistan on Saturday, the Ministry of External Affairs said.... read..

---

 

Covaxin for children proven to be safe in paediatric subjects in study: Bharat Biotech

Hyderabad based vaccine manufacturer Bharat Biotech on Thursday announced that BBV152 (Covaxin), its whole-virion inactivated COVID-19 vaccine candidate, has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study.... read..

---

 

Allow COVAXIN to get in the game: Tennis star Connors urges US to approve India's indigenously-developed COVID vaccine

As the US continues to register a record number of COVID-19 cases, American tennis legend Jimmy Connors has called on the Biden government and country's regulatory authority to recognise India's indigenously developed coronavirus vaccine COVAXIN for its v... read..

---

 

COVID-19: Himachal receives 2.80 lakh COVAXIN doses to vaccinate 15-18 age group from Jan 3

Himachal Pradesh government had received 2.80 lakh COVID-19 vaccine COVAXIN doses to vaccinate its young population of 15-18 age group from January 3.... read..

---

 

Covaxin found to be safe, immunogenic in 2-18 age group in phase 2, 3 study: Bharat Biotech

Hyderabad based vaccine manufacturer Bharat Biotech on Thursday announced that Covaxin (BBV152) has been found to be "safe, well-tolerated, and immunogenic" in the age group of 2-18 years in phase II/III study, said a company's statement.... read..

---

 

Only Covaxin to be administered to children aged 15-18 yrs

As the vaccination process for the teens aged 15 to 18 years will commence from January 3 across the nation, the government has said only Covaxin will be administered.... read..

---

 

COVID-19 vaccine: 15-18 age group to get Covaxin from Jan 3

Children aged between 15 to 18 who are eligible for vaccination from January 3 next year will only be administered doses of the Covaxin COVID-19 vaccine, sources in the Union Health Ministry said on Tuesday.... read..

---

 

Covaxin has shown good immune response in children during trials, says Dr NK Arora

Covaxin has shown that it has a very good immune response in children in trials, Dr NK Arora, Chairman of Covid Task Force working group, NTAGI, said on Sunday.... read..

---